The Body Contouring Devices And Procedures Market Size was valued at USD 5.55 Billion in 2023. The Global Body Contouring Devices And Procedures industry is projected to grow from USD 6.00 Billion in 2024 to USD 10.31 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.2% during the forecast period (2024 - 2032). Body contouring is a procedure involves in the alteration of the body part by improving the appearance. It refers to removal of the excess body fat. The various body contouring procedures available are body lift, body fat transfer, implants and abdominal etching.The factors such as increasing obese population is the major driving factor for the market. Beside this technological advance and improved surgical treatment with increased success rate has provided fuel for the growth of the market. High cost of the surgery may restrain the growth of the market.
In March 2023, the Picocare 250 Majesty, the first 250 Picosecond Nd: YAG laser in the world, was introduced for the first time in South India by Doctors Aesthetics Centre (DAC), one of the leading Indian efforts in aesthetics and skincare operations. Wontech, a South Korean company, has developed the Picocare 250 Majesty, an FDA-approved skin care laser, with the intention of revolutionizing the field of laser aesthetics and dermatology in India. Uneven skin texture, poor skin tone, fine lines and wrinkles, and enlarged pores are all treatable with the Picocare 250 Majesty's skin rejuvenation features.
In May 2023, DrSkin Med Spa launched the first and only body contouring device in Arizona that uses bespoke programming to maximize patient results.
For example, in April 2023, Apex Medical Corporation received FDA’s 510(k) clearance, allowing them to use Renuvion APR Handpiece “for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.” This showed the safety and effectiveness of Renuvion technology as well as continued commitment to securing specific clinical indications through collaboration with the FDA.
In March 2023, EON Smarter Body Contouring was cleared by the FDA for the back and thighs.
In May 2022 saw Dominion Aesthetic Technologies obtain clearance from the United States Food and Drug Administration (FDA) for its EON Smarter Body Contouring device for noninvasive laser lipolysis of adipose tissue of the flanks.
VLCC, in April 2022, announced a new non-invasive body contouring slimming treatment in Oman that takes away excess fat from the body without any surgical procedure. The treatment makes use of laser technology approved by the US FDA.
In June 2021, there were more than 1.9 billion people aged at least eighteen years who weighed overweight. Of these, close to six hundred fifty million were obese; Thirty-nine percent were overweight among those over eighteen years old, while thirteen percent were obese during the same year. Allergan Aesthetics’ acquisition of Soliton marked an expansion of the company’s body contouring portfolio last month.
Allergan Aesthetics entered into an agreement with Soliton in May 2021 whereby Allergan will acquire Soliton, including RESONICTM, its Rapid Acoustic Pulse device, which is approved by the U.S. Food and Drug Administration (FDA) as a non-invasive treatment for short-term advancement in appearance of cellulite via their own Coolsculpting Elite Body Contouring treatment portfolio.
According to WHO, in 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 650 million were obese, 39% of adults aged 18 years and over were overweight in the same year, and 13% were obese. Most of the world's population live in countries where overweight and obesity kills more people than underweight
The rising prevalence of obesity is a key reason propelling the industry forward. Market expansion has also been fueled by developments in technology and the rise of surgical procedures with higher success rates. The market might be stunted by the high price of the procedure. Invasive, non-invasive, and minimally invasive technology are all available for use in the pursuit of body contouring. Liposuction is one option, but there are many less invasive treatments, such as cryo lipolysis, injectable lipolysis, radiofrequency lipolysis, and laser lipolysis. The primary objective of body contouring operations is to get rid of excess fat and make the treated region firmer.
The worldwide market is expected to be driven by the increasing prevalence of obesity caused by poor lifestyle choices. Demand for these methods is predicted to rise as improvements in their safety and efficacy lead to longer lifespans. The market will likely grow in the next years as a result of initiatives done by large firms for product research and distribution, such as mergers and acquisitions, new product releases, and alliances.
The appearance of the COVID-19 epidemic, however, had an impact on the aesthetics industry as a whole. But many experts in the field of aesthetics think the epidemic would boost demand for body shaping procedures. Many women are more open to and interested in nonsurgical aesthetic operations than they were before the epidemic, as reported by the American Society of Plastic Surgeons.
The Body contouring devices and procedures market has been segmented into type, procedure, and end user.
By type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. The non-invasive & minimally invasive devices segment is estimated to hold major market share in the body contouring devices and procedures market due to the huge investments by major market players for the development of advanced technologies and equipment.Based on procedure, the market has been segmented into non-surgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others.
The market, by end user, has been segmented into hospitals & clinics, research institutes & Organization, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The body contouring devices and procedures market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Body Contouring Devices and Procedures Market has been segmented into Western Europe and Eastern Europe. The Western Europe Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The body contouring devices and procedures market in the Middle East & Africa has been segmented into the Middle East and Africa.
May 2023: Liposuction is the most common form of cosmetic surgery, and Apyx Medical Corporation (NASDAQ: APYX) announced that it has received 510(k) clearance from the U.S. FDA for the use of its APR Handpiece in procedures for coagulation of soft tissues following liposuction. Renuvion, which had previously received FDA 510(k) authorization for use in the treatment of neck laxity, face rejuvenation operations, and the contraction of soft tissue, now allows surgeons to achieve liposuction-like outcomes with minimum downtime.
Geographically, the Americas is anticipated to dominate the body contouring devices and procedures market owing to the high domestic income, and presence of major market players. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion.
Europe is expected to hold the second largest position in the body contouring devices and procedures market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).
The body contouring devices and procedures market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.
The Middle East & Africa has the lowest share of the body contouring devices and procedures market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Key players:
Some of the prominent players in the body contouring devices and procedures market are
Intended Audience:
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 5.55 Billion |
| Market Size 2024 | USD 6.00Â Billion |
| Market Size 2032 | USD 10.31 Billion |
| Compound Annual Growth Rate (CAGR) | 6.2% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Procedure, End-User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd, Bausch Health Companies, Inc, Lumenis, Merz Pharma GmbH & Co., Palomar Medical Technologies Inc., Sound Surgical Technologies LLC., Zeltiq Aesthetics, Chromogenex Technologies LTD, UltraShape Ltd, Fotona, Misonix Inc., Medicis Pharmaceutical Corporation, Sientra Inc., Invasix Ltd, Erchonia Inc, Lutronic |
| Key Market Opportunities | Increasing number of minimally invasive procedures |
| Key Market Dynamics | Rising prevalence of obesity and the rise of surgical procedures with higher success rates |
Body Contouring Devices and Procedures Market Highlights:
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
